SCOPUS 정보 검색 플랫폼

Volumn 214, Issue 4, 2002, Pages 188-194

Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children;Effektive rezidivtherapie der akuten myeloischen leukämie im kindesalter mit liposomalem daunorubicin und cytarabin

(6) Reinhardt, Dirk a Hempel, G a Fleischhack, G b Schulz, A c Boos, J a Creutzig, U a

a UNIVERSITY OF MÜNSTER (Germany)

b UNIVERSITY OF BONN (Germany)

c UNIVERSITY OF ULM (Germany)

Author keywords

Acute myeloid leukemia; Cardiotoxicity; Children; Liposomal daunorubicin; Relapse

Indexed keywords

ANTHRACYCLINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; LIPOSOME; TIOGUANINE; ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; DOSE RESPONSE; DRUG FORMULATION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; PHARMACOKINETICS; PROGNOSIS; SEPTICEMIA; SIDE EFFECT; STEM CELL TRANSPLANTATION; SURVIVAL TIME; FOLLOW UP; INFANT; MORTALITY; PRESCHOOL CHILD; REMISSION; SURVIVAL RATE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYTARABINE; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENGLISH ABSTRACT; FEMALE; FOLLOW-UP STUDIES; HUMAN; INFANT; LEUKEMIA, MYELOCYTIC, ACUTE; LIPOSOMES; MALE; REMISSION INDUCTION; STEM CELL TRANSPLANTATION; SURVIVAL RATE; HUMANS;

EID: 0036629063 PISSN: 03008630 EISSN: None Source Type: Journal
DOI: 10.1055/s-2002-33185 Document Type: Article

Times cited : (21)

References (26)

1
- 0035131891
- Combination chemotherapy utilizing continuous infusion of intermediate-dose cytarabine for refractory or recurrent acute myeloid leukemia
- (2001) Leuk Res , vol.25 , pp. 213-216
- Bahng, H.¹ Lee, J.H.² Ahn, J.H.³ Lee, J.H.⁴ Lee, J.S.⁵ Kim, S.H.⁶ Kim, W.K.⁷ Lee, K.H.⁸

2
- 0035877289
- Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with Daunoxome
- (2001) J Chromatogr B Biomed Sci Appl , vol.757 , pp. 257-267
- Bellot, R.¹ Pouna, P.² Robert, J.³

3
- 0035396908
- High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia
- (2001) Cancer , vol.92 , pp. 7-14
- Cortes, J.¹ Estey, E.² O'Brien, S.³ Giles, F.⁴ Shen, Y.⁵ Koller, C.⁶ Beran, M.⁷ Thomas, D.⁸ Keating, M.⁹ Kantarjian, H.¹⁰

4
- 0035077367
- Idarubicin improves blast cell clearance during induction therapy in children with AML: Results of study AML-BFM 93
- AML-BFM Study Group
- (2001) Leukemia , vol.15 , pp. 348-354
- Kreutzig, U.¹ Ritter, J.² Zimmermann, M.³ Hermann, J.⁴ Gadner, H.⁵ Sawatzki, D.B.⁶ Niemeyer, C.M.⁷ Schwabe, D.⁸ Selle, B.⁹ Boos, J.¹⁰ Kuhl, J.¹¹ Feldges, A.¹²

5
- 0035873817
- Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: Results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Munster 93
- (2001) J Clin Oncol , vol.19 , pp. 2705-2713
- Creutzig, U.¹ Ritter, J.² Zimmermann, M.³ Reinhardt, D.⁴ Hermann, J.⁵ Berthold, F.⁶ Henze, G.⁷ Jurgens, H.⁸ Kabisch, H.⁹ Havers, W.¹⁰ Reiter, A.¹¹ Kluba, U.¹² Niggli, F.¹³ Gadner, H.¹⁴

6
- 0033625107
- Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute-myeloid leukemia
- (2000) J Clin Oncol , vol.18 , pp. 1867-1875
- Dahl, G.V.¹ Lacayo, N.J.² Brophy, N.³ Dunussi-Joannopoulos, K.⁴ Weinstein, H.J.⁵ Chang, M.⁶ Sikic, B.I.⁷ Arceci, R.J.⁸

7
- 0031812317
- IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), an effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: Experiences of a phase II trial
- (1998) Br J Haematol , vol.102 , pp. 647-655
- Fleischhack, G.¹ Hasan, C.² Graf, N.³ Mann, G.⁴ Bode, U.⁵

8
- 0031660433
- Epidemiology of anthracycline cardiotoxicity in children and adults
- (1998) Semin Oncol , vol.25 , pp. 72-85
- Grenier, M.A.¹ Lipshultz, S.E.²

9
- 0028054331
- Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome)
- (1994) Invest New Drugs , vol.12 , pp. 103-110
- Guaglianone, P.¹ Chan, K.² DelaFlor-Weiss, E.³ Hanisch, R.⁴ Jeffers, S.⁵ Sharma, D.⁶ Muggia, F.⁷

10
- 0035879915
- Quantification of daunorubicin and daunorubicinol in plasma by capillary electrophoresis
- (2001) J Chromatogr B Biomed Sci Appl , vol.758 , pp. 221-228
- Hempel, G.¹ Schulze-Westhoff, P.² Flege, S.³ Boos, J.⁴

11
- 0021029382
- Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation
- (1983) Cancer Res , vol.43 , pp. 5427-5432
- Herman, E.H.¹ Rahman, A.² Ferrans, V.J.³ Vick, J.A.⁴ Schein, P.S.⁵

12
- 0034599634
- Modulation of daunorubicin toxicity by liposomal encapsulation and use of specific inhibitors in vitro
- (2000) Toxicology , vol.144 , pp. 189-195
- Iffert, T.¹ Soldan, M.² Moeller, A.³ Maser, E.⁴

13
- 0032809362
- A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia
- Southwest Oncology Group Study
- (1999) Leuk Res , vol.23 , pp. 787-794
- Karanes, C.¹ Kopecky, K.J.² Head, D.R.³ Grever, M.R.⁴ Hynes, H.E.⁵ Kraut, E.H.⁶ Vial, R.H.⁷ Lichtin, A.⁸ Nand, S.⁹ Samlowski, W.E.¹⁰ Appelbaum, F.R.¹¹

14
- 0030660703
- A pilot study of continuous infusion Ara-C in combination with rhG-CSF in relapsed childhood acute myeloid leukemia
- (1997) Leuk Lymphoma , vol.26 , pp. 589-593
- Laver, J.¹ Schearer, P.² Krance, R.³ Hurwitz, C.A.⁴ Srivastava, D.K.⁵ Weinstein, H.J.⁶ Mirro, J.⁷

16
- 0031894189
- Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia
- (1998) J Clin Oncol , vol.16 , pp. 545-550
- Nysom, K.¹ Holm, K.² Lipsitz, S.R.³ Mone, S.M.⁴ Colan, S.D.⁵ Orav, E.J.⁶ Sallan, S.E.⁷ Olsen, J.H.⁸ Hertz, H.⁹ Jacobsen, J.R.¹⁰ Lipshultz, S.E.¹¹

17
- 0033774617
- Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia
- (2000) Cancer Chemother Pharmacol , vol.46 , pp. 279-286
- Pea, F.¹ Russo, D.² Michieli, M.³ Baraldo, M.⁴ Ermacora, A.⁵ Damiani, D.⁶ Baccarani, M.⁷ Furlanut, M.⁸

18
- 0035064891
- Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF
- (2001) Ann Hematol , vol.80 , pp. 144-149
- Platzbecker, U.¹ Thiede, C.² Freiberg-Richter, J.³ Helwig, A.⁴ Mohr, B.⁵ Prange, G.⁶ Fussel, M.⁷ Kohler, T.⁸ Ehinger, G.⁹ Bornhauser, M.¹⁰

19
- 0344309515
- Development of the model of rat isolated perfused heart for the evaluation of anthracycline caridotoxicity and its circumvention
- (1996) Br J Pharmacol , vol.117 , pp. 1593-1599
- Pouna, P.¹ Bonoron-Adele, S.² Gouverneur, G.³ Tariosse, L.⁴ Besse, P.⁵ Robert, J.⁶

20
- 0030317942
- Anthracycline-induced cardiotoxicity
- (1996) Ann Intern Med , vol.125 , pp. 47-58
- Shan, K.¹ Lincoff, A.M.² Young, J.B.³

21
- 0031682976
- Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemia
- (1998) Leukemia , vol.12 , pp. 1534-1538
- Stahnke, K.¹ Boos, J.² Bender-Gotze, C.³ Ritter, J.⁴ Zimmermann, M.⁵ Creutzig, U.⁶

22
- 0029963320
- Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: A Pediatric Oncology Group randomized phase II study
- (1996) J Clin Oncol , vol.14 , pp. 1521-1525
- Steuber, C.P.¹ Krischer, J.² Holbrook, T.³ Camitta, B.⁴ Land, V.⁵ Sexauer, C.⁶ Mahoney, D.⁷ Weinstein, H.⁸

23
- 0034118520
- Length of first remission and karyotype: Important prognostic factors for treatment of relapsed acute myeloid leukaemia
- (2000) Br J Haematol , vol.109 , pp. 671
- Webb, D.K.¹

24
- 0032924997
- Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial
- MRC Childhood Leukaemia Working Party
- (1999) Leukemia , vol.13 , pp. 25-31
- Webb, D.K.¹ Wheatley, K.² Harrison, G.³ Stevens, R.F.⁴ Hann, I.M.⁵

25
- 0028132188
- Cytosine arabinoside and mitoxantrone induction chemotherapy followed by bone marrow transplantation or chemotherapy for relapsed or refractory pediatric acutemyeloid leukemia
- (1994) Leukemia , vol.8 , pp. 1626-1630
- Wells, R.J.¹ Gold, S.H.² Krill, C.E.³ Cornelius, A.S.⁴ Byrd, R.L.⁵ Ruymann, F.B.⁶ Feusner, J.⁷ White, M.L.⁸ Cairo, M.S.⁹

26
- 0032868639
- Late cardiotoxicity of anthracyclines in children with acute leukemia
- (1999) Klin Padiatr , vol.211 , pp. 356-359
- Zalewska-Szewczyk, B.¹ Lipiec, J.² Bodalski, J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.